Skip to main content
Erschienen in: Calcified Tissue International 6/2009

01.06.2009

May an Altered Hypothalamo–Pituitary–Adrenal Axis Contribute to Cortical Bone Damage in Primary Hyperparathyroidism?

verfasst von: Laura Gianotti, Francesco Tassone, Anna Pia, Silvia Bovio, Giuseppe Reimondo, Gianluca Visconti, Massimo Terzolo, Giorgio Borretta

Erschienen in: Calcified Tissue International | Ausgabe 6/2009

Einloggen, um Zugang zu erhalten

Abstract

Cortisol secretion has been reported to be increased in primary hyperparathyroidism (PHPT). Our aim was to evaluate circulating and urinary cortisol levels and the relationships with biochemical and bone parameters in patients with PHPT at the time of diagnosis. We studied 180 consecutive patients with PHPT (mean age ± SD 60.0 ± 13.2 years; F/M 140/40, BMI 25.8 ± 4.8 kg/m2) and 56 subjects with incidentally discovered adrenal adenoma who served as controls (age 56.2 ± 12.8 years, F/M 40/16, BMI 25.7 ± 3.9 kg/m2). Serum morning and midnight cortisol and urinary free cortisol were measured in both groups. In PHPT patients bone mineral density was measured at the lumbar spine, femur, and forearm. Serum morning cortisol and urinary cortisol were similar in PHPT patients and controls, whereas midnight cortisol was higher in PHPT patients (5.3 ± 4.7 vs. 2.9 ± 0.9 μg/dL, P = 0.001). In this group, midnight cortisol correlated positively with age (r = 0.27, P = 0.008) and negatively with forearm (r = −0.36, P = 0.003) and total-femur T score (r = −0.30, P = 0.02). Multivariate regression analysis, including age, calcium, parathyroid hormone (PTH), and midnight cortisol as independent variables and forearm T score as dependent variable, indicated that age (β = –0.29, P < 0.0001), PTH (β = –0.33, P < 0.0001), and midnight cortisol (β = –0.14, P < 0.04) were independently associated with forearm T score. Our findings show increased midnight cortisol levels in patients with PHPT, indicating a subtle alteration of the hypothalamo–pituitary–adrenal axis dynamics that is unrelated to the degree of disease activity; further data are needed to demonstrate the supplementary effect of this subtle alteration to bone damage in this condition.
Literatur
1.
Zurück zum Zitat Khan A, Bilezikian J (2000) Primary hyperparathyroidism: pathophysiology and impact on bone. CMAJ 163:184–187PubMed Khan A, Bilezikian J (2000) Primary hyperparathyroidism: pathophysiology and impact on bone. CMAJ 163:184–187PubMed
2.
Zurück zum Zitat Silverberg SJ, Shane E, Dempster DW, Bilezikian JP (1999) The effects of vitamin D insufficiency in patients with primary hyperparathyroidism. Am J Med 107:561–567PubMedCrossRef Silverberg SJ, Shane E, Dempster DW, Bilezikian JP (1999) The effects of vitamin D insufficiency in patients with primary hyperparathyroidism. Am J Med 107:561–567PubMedCrossRef
3.
Zurück zum Zitat Gianotti L, Tassone F, Cesario F, Pia A, Razzore P, Magro G, Piovesan A, Borretta G (2006) A slight decrease in renal function further impairs bone mineral density in primary hyperparathyroidism. J Clin Endocrinol Metab 91:3011–3016PubMedCrossRef Gianotti L, Tassone F, Cesario F, Pia A, Razzore P, Magro G, Piovesan A, Borretta G (2006) A slight decrease in renal function further impairs bone mineral density in primary hyperparathyroidism. J Clin Endocrinol Metab 91:3011–3016PubMedCrossRef
4.
Zurück zum Zitat Rosenberg J, Pines M, Hurwitz S (1987) Response of adrenal cells to parathyroid stimulation. J Endocrinol 112:431–437PubMedCrossRef Rosenberg J, Pines M, Hurwitz S (1987) Response of adrenal cells to parathyroid stimulation. J Endocrinol 112:431–437PubMedCrossRef
5.
Zurück zum Zitat Mazzocchi G, Aragona F, Malendowicz LK, Nussdorfer GG (2001) PTH and PTH-related peptide enhance steroid secretion from human adrenocortical cells. Am J Physiol Endocrinol Metab 280:E209–E213PubMed Mazzocchi G, Aragona F, Malendowicz LK, Nussdorfer GG (2001) PTH and PTH-related peptide enhance steroid secretion from human adrenocortical cells. Am J Physiol Endocrinol Metab 280:E209–E213PubMed
6.
Zurück zum Zitat Yoshida T, Mio M, Tasaka K (1993) Ca++-induced cortisol secretion from permeabilized bovine adrenocortical cells: the roles of calmodulin, protein kinase C and cyclic AMP. Pharmacology 46:181–192PubMedCrossRef Yoshida T, Mio M, Tasaka K (1993) Ca++-induced cortisol secretion from permeabilized bovine adrenocortical cells: the roles of calmodulin, protein kinase C and cyclic AMP. Pharmacology 46:181–192PubMedCrossRef
7.
Zurück zum Zitat Fuleihan GE-H, Brown EM, Gleason R, Scott J, Adler GK (1996) Calcium modulation of adrenocorticotropin levels in women—a clinical research study. J Clin Endocrinol Metab 81:932–936PubMedCrossRef Fuleihan GE-H, Brown EM, Gleason R, Scott J, Adler GK (1996) Calcium modulation of adrenocorticotropin levels in women—a clinical research study. J Clin Endocrinol Metab 81:932–936PubMedCrossRef
8.
Zurück zum Zitat Brismar K, Werner S, Bucht E, Wetterber L (1987) Melatonin, cortisol, prolactin, and calcitonin secretion in primary hyperparathyroidism before and after surgery. J Pineal Res 4:277–285PubMedCrossRef Brismar K, Werner S, Bucht E, Wetterber L (1987) Melatonin, cortisol, prolactin, and calcitonin secretion in primary hyperparathyroidism before and after surgery. J Pineal Res 4:277–285PubMedCrossRef
9.
Zurück zum Zitat Richards AM, Espiner EA, Nicholls MG, Ikram H, Hamilton EJ, Maslowski AH (1988) Hormone, calcium and blood pressure relationships in primary hyperparathyroidism. J Hypertens 6:747–752PubMedCrossRef Richards AM, Espiner EA, Nicholls MG, Ikram H, Hamilton EJ, Maslowski AH (1988) Hormone, calcium and blood pressure relationships in primary hyperparathyroidism. J Hypertens 6:747–752PubMedCrossRef
10.
Zurück zum Zitat Linder J, Brimar K, Granberg PO, Wetterberg L, Werner S (1988) Characteristic changes in psychiatric symptoms, cortisol and melatonin but not prolactin in primary hyperparathyroidism. Acta Psychiatr Scand 78:32–40PubMedCrossRef Linder J, Brimar K, Granberg PO, Wetterberg L, Werner S (1988) Characteristic changes in psychiatric symptoms, cortisol and melatonin but not prolactin in primary hyperparathyroidism. Acta Psychiatr Scand 78:32–40PubMedCrossRef
11.
Zurück zum Zitat Patschan D, Loddenkemper K, Buttgereit F (2001) Molecular mechanisms of glucocorticoid-induced osteoporosis. Bone 29:498–505PubMedCrossRef Patschan D, Loddenkemper K, Buttgereit F (2001) Molecular mechanisms of glucocorticoid-induced osteoporosis. Bone 29:498–505PubMedCrossRef
12.
Zurück zum Zitat Lafage-Proust MH, Boudignon B, Thomas T (2003) Glucocorticoid-induced osteoporosis: pathophysiological data and recent treatments. Joint Bone Spine 70:109–118PubMedCrossRef Lafage-Proust MH, Boudignon B, Thomas T (2003) Glucocorticoid-induced osteoporosis: pathophysiological data and recent treatments. Joint Bone Spine 70:109–118PubMedCrossRef
13.
Zurück zum Zitat Mancini T, Doga M, Mazziotti G, Giustina A (2004) Cushing’s syndrome and bone. Pituitary 7:249–252PubMedCrossRef Mancini T, Doga M, Mazziotti G, Giustina A (2004) Cushing’s syndrome and bone. Pituitary 7:249–252PubMedCrossRef
14.
Zurück zum Zitat Rubin MR, Biliezikian JP (2002) The role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis: a re-examination of the evidence. J Clin Endocrinol Metab 87:4033–4041PubMedCrossRef Rubin MR, Biliezikian JP (2002) The role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis: a re-examination of the evidence. J Clin Endocrinol Metab 87:4033–4041PubMedCrossRef
15.
Zurück zum Zitat National Institutes of Health Conference (1991) Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement. Ann Intern Med 114:593–597 National Institutes of Health Conference (1991) Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement. Ann Intern Med 114:593–597
16.
Zurück zum Zitat Terzolo M, Pia A, Alì A, Osella G, Reimondo G, Bovio S, Daffara F, Procopio M, Paccotti P, Borretta G, Angeli A (2002) Adrenal incidentaloma: a new cause of the metabolic sindrome? J Clin Endocrinol Metab 87:998–1003PubMedCrossRef Terzolo M, Pia A, Alì A, Osella G, Reimondo G, Bovio S, Daffara F, Procopio M, Paccotti P, Borretta G, Angeli A (2002) Adrenal incidentaloma: a new cause of the metabolic sindrome? J Clin Endocrinol Metab 87:998–1003PubMedCrossRef
17.
Zurück zum Zitat Findling JW, Raff H (2006) Cushing’s syndrome: important issues in diagnosis and management. J Clin Endocrinol Metab 91:3746–3746PubMedCrossRef Findling JW, Raff H (2006) Cushing’s syndrome: important issues in diagnosis and management. J Clin Endocrinol Metab 91:3746–3746PubMedCrossRef
18.
Zurück zum Zitat Terzolo M, Bovio S, Reimondo G, Pia A, Osella G, Borretta G, Angeli A (2005) Subclinical Cushing’s syndrome in adrenal incidentalomas. Endocrinol Metab Clin North Am 34:423–439PubMedCrossRef Terzolo M, Bovio S, Reimondo G, Pia A, Osella G, Borretta G, Angeli A (2005) Subclinical Cushing’s syndrome in adrenal incidentalomas. Endocrinol Metab Clin North Am 34:423–439PubMedCrossRef
19.
Zurück zum Zitat Newell-Price J, Trainer P, Besser M, Grossman A (1988) The diagnosis and differential diagnosis of Cushing’s syndrome and pseudo-Cushing’s states. Endocr Rev 19:647–672CrossRef Newell-Price J, Trainer P, Besser M, Grossman A (1988) The diagnosis and differential diagnosis of Cushing’s syndrome and pseudo-Cushing’s states. Endocr Rev 19:647–672CrossRef
20.
Zurück zum Zitat Ferrari E, Cravello L, Muzzoni B, Casarotti D, Paltro M, Solerte SB, Fioravanti M, Cuzzoni G, Pontiggia B, Magri F (2001) Age-related changes of the hypothalamic–pituitary–adrenal axis: pathophysiological correlates. Eur J Endocrinol 144:319–329PubMedCrossRef Ferrari E, Cravello L, Muzzoni B, Casarotti D, Paltro M, Solerte SB, Fioravanti M, Cuzzoni G, Pontiggia B, Magri F (2001) Age-related changes of the hypothalamic–pituitary–adrenal axis: pathophysiological correlates. Eur J Endocrinol 144:319–329PubMedCrossRef
21.
Zurück zum Zitat Chrousos GP, Kino T (2007) Glucocorticoid action networks and complex psychiatric and/or somatic disorders. Stress 10:213–219PubMedCrossRef Chrousos GP, Kino T (2007) Glucocorticoid action networks and complex psychiatric and/or somatic disorders. Stress 10:213–219PubMedCrossRef
22.
Zurück zum Zitat Chiodini I, Mascia ML, Muscarella S, Battista C, Minisola S, Arosio M, Santini SA, Guglielmi G, Carnevale V, Scillitani A (2007) Subclinical hypercortisolism among outpatients referred for osteoporosis. Ann Intern Med 147:541–548PubMed Chiodini I, Mascia ML, Muscarella S, Battista C, Minisola S, Arosio M, Santini SA, Guglielmi G, Carnevale V, Scillitani A (2007) Subclinical hypercortisolism among outpatients referred for osteoporosis. Ann Intern Med 147:541–548PubMed
23.
Zurück zum Zitat Torlontano M, Chiodini I, Pileri M, Guglielmi G, Cammina M, Modoni S, Carnevale V, Trischitta V, Scillitani A (1999) Altered bone mass and turnover in female patients with adrenal incidentaloma: the effect of subclinical hypercortisolism. J Clin Endocrinol Metab 84:2381–2385PubMedCrossRef Torlontano M, Chiodini I, Pileri M, Guglielmi G, Cammina M, Modoni S, Carnevale V, Trischitta V, Scillitani A (1999) Altered bone mass and turnover in female patients with adrenal incidentaloma: the effect of subclinical hypercortisolism. J Clin Endocrinol Metab 84:2381–2385PubMedCrossRef
24.
Zurück zum Zitat Chiodini I, Torlontano M, Carnevale V, Trischitta V, Scillitani A (2008) Skeletal involvement in adult patients with endogenous hypercortisolism. J Endocrinol Invest 31:267–276PubMed Chiodini I, Torlontano M, Carnevale V, Trischitta V, Scillitani A (2008) Skeletal involvement in adult patients with endogenous hypercortisolism. J Endocrinol Invest 31:267–276PubMed
25.
Zurück zum Zitat Cooper MS (2008) 11Beta-hydroxysteroid dehydrogenase: a regulator of glucocorticoid response in osteoporosis. J Endocrinol Invest 31:16–21PubMed Cooper MS (2008) 11Beta-hydroxysteroid dehydrogenase: a regulator of glucocorticoid response in osteoporosis. J Endocrinol Invest 31:16–21PubMed
Metadaten
Titel
May an Altered Hypothalamo–Pituitary–Adrenal Axis Contribute to Cortical Bone Damage in Primary Hyperparathyroidism?
verfasst von
Laura Gianotti
Francesco Tassone
Anna Pia
Silvia Bovio
Giuseppe Reimondo
Gianluca Visconti
Massimo Terzolo
Giorgio Borretta
Publikationsdatum
01.06.2009
Verlag
Springer-Verlag
Erschienen in
Calcified Tissue International / Ausgabe 6/2009
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-009-9245-7

Weitere Artikel der Ausgabe 6/2009

Calcified Tissue International 6/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.